new angiotensin II (AII) antagonist, Avapro (irbesartan)
July 1998
You'll see a new angiotensin II (AII) antagonist, Avapro(irbesartan)...from Bristol-Myers Squibb and Sanofi Winthrop.
It's the third AII antagonist on the market...after Cozaar(losartan) and Diovan (valsartan).
These are all approved for hypertension...either alone orwith a thiazide diuretic
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive